Insider Trading March 2, 2026

M&T Bank Senior Executive Disposes $1.84 Million in Shares; Exercises Options Worth $702,438

Sale and option exercise coincide with quarterly results, dividend declaration and a leadership appointment

By Sofia Navarro MTB
M&T Bank Senior Executive Disposes $1.84 Million in Shares; Exercises Options Worth $702,438
MTB

M&T Bank Corp Senior Executive Vice President Michael A. Wisler sold 8,236.977 shares of common stock on February 26, 2026, for $1,840,809 and exercised options to acquire 4,751 shares with a total exercise value of $702,438. The transactions occurred amid the bank’s fourth-quarter earnings beat, a declared quarterly dividend and a regional leadership appointment, while an analyst maintained an Outperform rating and set a $220.00 price target.

Key Points

  • Michael A. Wisler sold 8,236.977 shares on February 26, 2026, receiving $1,840,809; sale prices ranged from $223.397 to $223.81.
  • Wisler exercised options to acquire 4,751 shares on the same day, with exercise prices of $138.10 and $156, for a total exercise value of $702,438.
  • M&T reported fourth-quarter EPS of $4.72 versus $4.47 expected, revenue of $2.47 billion in line with projections, declared a $1.50 quarterly dividend payable March 31, 2026, and announced a regional leadership appointment; RBC raised its price target to $220.00 and maintained an Outperform rating.

Senior Executive Vice President Michael A. Wisler of M&T Bank Corp (NYSE: MTB) carried out a sale of 8,236.977 shares of the company’s common stock on February 26, 2026, generating proceeds of $1,840,809. The sale was executed across multiple trades at per-share prices that ranged from $223.397 to $223.81, with the weighted price for the block reported as $223.4812.

On the same date, Wisler also exercised stock options to acquire 4,751 shares of M&T common stock. The combined cost of exercising those options amounted to $702,438. The option exercise prices associated with those shares were $138.10 and $156, respectively.

These insider transactions took place against a backdrop of reported quarterly financial results and corporate developments. For the fourth quarter, M&T Bank reported earnings per share of $4.72, surpassing analysts’ expectations of $4.47. The bank’s revenue for the quarter totaled $2.47 billion, which the company said was in line with projections.

In addition to the earnings release, M&T declared a quarterly cash dividend of $1.50 per share. That dividend is scheduled to be paid on March 31, 2026, to shareholders of record as of March 2, 2026.

On the management front, Jeff Carpenter has been named Regional President of Massachusetts. Carpenter brings over 20 years of experience in corporate and specialty banking to the role and will oversee a range of banking operations, including retail and commercial banking within the region.

Following these developments, RBC Capital adjusted its price target for M&T Bank to $220.00 while maintaining an Outperform rating on the stock. The firm cited the bank’s business model in support of that view.

Taken together, the insider sale and option exercise; the company’s fourth-quarter results, which included an earnings beat and revenue that met expectations; the declared quarterly dividend with its March record and payment dates; the appointment of a new regional president; and the analyst price-target action comprise the primary public developments for M&T Bank reported around late February and into March 2026.

Risks

  • Market reaction to the executive share sale and option exercises is unknown and could contribute to near-term share-price movement.
  • Sustaining or improving on fourth-quarter EPS of $4.72 is not established by this report and remains an open question for future periods.
  • Future valuation outcomes relative to RBC Capital’s $220.00 price target and maintained Outperform rating are uncertain.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026